Bulevirtide vs Icotrokinra

Overview

Bulevirtide is primarily a antiviral peptide, while Icotrokinra is used for immune support.

This page compares Bulevirtide and Icotrokinra across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. Bulevirtide is categorised under Antiviral, while Icotrokinra falls under Immune Support. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Bulevirtide: FDA-approved. Icotrokinra: FDA-approved.

Can you stack them?

Some protocols combine peptides, but stacking Bulevirtide and Icotrokinra has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Bulevirtide and Icotrokinra?

Bulevirtide is primarily a antiviral peptide, while Icotrokinra is used for immune support. Bulevirtide is FDA-approved for one or more indications, whereas Icotrokinra is FDA-approved for one or more indications.

What is Bulevirtide used for?

First/only FDA-approved treatment for chronic hepatitis delta virus (HDV). FDA accelerated approval May 22, 2026. Brand: Hepcludex (Gilead).

What is Icotrokinra used for?

Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.

Can you take Bulevirtide and Icotrokinra together?

Some users combine peptides within a single protocol, but stacking Bulevirtide and Icotrokinra has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is Bulevirtide or Icotrokinra FDA-approved?

Bulevirtide is FDA-approved for one or more indications. Icotrokinra is FDA-approved for one or more indications.